INTRODUCTION: Although several studies have evaluated risk factors for death after lung transplantation (LTx), few studies have focused on the highest-risk recipients. We undertook this study to evaluate the effect of high lung allocation scores (LAS), ventilator support, and extracorporeal membrane oxygenation (ECMO) support on outcomes after LTx. METHODS: We retrospectively reviewed all LTx recipients in the United Network for Organ Sharing database. Primary stratification was by recipient acuity at the time of LTx. The 3 strata consisted of (1) recipients in the highest LAS quartile (LAS ≥ 48.4), (2) those requiring ventilator support, and (3) those requiring ECMO support. The primary outcome was 1-year mortality. Sub-group analysis focused on temporal trends. RESULTS: From May 2005 to June 2011, 9,267 adults underwent LTx. Before LTx, 1,874 (20.2%) were in the highest LAS quartile, 526 (5.7%) required ventilator support, and 122 (1.3%) required ECMO support. Unadjusted analysis showed decreased 1-year survival associated with ventilator (67.7%) and ECMO support (57.6%) compared with the highest LAS quartile (81.0%; p < 0.001 for each comparison). These differences persisted on adjusted analysis for ventilator support (hazard ratio, 1.99, p < 0.001) and ECMO support (hazard ratio, 3.03; p < 0.001). Increasing annual center volume was associated with decreased mortality. In patients bridged to LTx with ECMO support, 1-year survival improved over time (coefficient, 8.03% per year; p = 0.06). CONCLUSIONS: High-acuity LTx recipients, particularly those bridged with ventilator or ECMO support, have increased short-term mortality after LTx. However, since the introduction of the LAS, high-risk patients have demonstrated improving outcomes, particularly at high-volume centers.
INTRODUCTION: Although several studies have evaluated risk factors for death after lung transplantation (LTx), few studies have focused on the highest-risk recipients. We undertook this study to evaluate the effect of high lung allocation scores (LAS), ventilator support, and extracorporeal membrane oxygenation (ECMO) support on outcomes after LTx. METHODS: We retrospectively reviewed all LTx recipients in the United Network for Organ Sharing database. Primary stratification was by recipient acuity at the time of LTx. The 3 strata consisted of (1) recipients in the highest LAS quartile (LAS ≥ 48.4), (2) those requiring ventilator support, and (3) those requiring ECMO support. The primary outcome was 1-year mortality. Sub-group analysis focused on temporal trends. RESULTS: From May 2005 to June 2011, 9,267 adults underwent LTx. Before LTx, 1,874 (20.2%) were in the highest LAS quartile, 526 (5.7%) required ventilator support, and 122 (1.3%) required ECMO support. Unadjusted analysis showed decreased 1-year survival associated with ventilator (67.7%) and ECMO support (57.6%) compared with the highest LAS quartile (81.0%; p < 0.001 for each comparison). These differences persisted on adjusted analysis for ventilator support (hazard ratio, 1.99, p < 0.001) and ECMO support (hazard ratio, 3.03; p < 0.001). Increasing annual center volume was associated with decreased mortality. In patients bridged to LTx with ECMO support, 1-year survival improved over time (coefficient, 8.03% per year; p = 0.06). CONCLUSIONS: High-acuity LTx recipients, particularly those bridged with ventilator or ECMO support, have increased short-term mortality after LTx. However, since the introduction of the LAS, high-risk patients have demonstrated improving outcomes, particularly at high-volume centers.
Authors: Jonathan B Orens; Marc Estenne; Selim Arcasoy; John V Conte; Paul Corris; Jim J Egan; Thomas Egan; Shaf Keshavjee; Christiane Knoop; Robert Kotloff; Fernando J Martinez; Steven Nathan; Scott Palmer; Alec Patterson; Lianne Singer; Gregory Snell; Sean Studer; J L Vachiery; Allan R Glanville Journal: J Heart Lung Transplant Date: 2006-07 Impact factor: 10.247
Authors: J Wytze Vermeijden; Jan G Zijlstra; Michiel E Erasmus; Wim van der Bij; Erik A Verschuuren Journal: J Heart Lung Transplant Date: 2009-04 Impact factor: 10.247
Authors: O Moen; E Fosse; E Dregelid; V Brockmeier; C Andersson; K Høgåsen; P Venge; T E Mollnes; P Kierulf Journal: Ann Thorac Surg Date: 1996-10 Impact factor: 4.330
Authors: E Fosse; O Moen; E Johnson; G Semb; V Brockmeier; T E Mollnes; M K Fagerhol; P Venge Journal: Ann Thorac Surg Date: 1994-08 Impact factor: 4.330
Authors: George J Arnaoutakis; Timothy J George; Jeremiah G Allen; Stuart D Russell; Ashish S Shah; John V Conte; Eric S Weiss Journal: J Thorac Cardiovasc Surg Date: 2012-01 Impact factor: 5.209
Authors: T M Egan; S Murray; R T Bustami; T H Shearon; K P McCullough; L B Edwards; M A Coke; E R Garrity; S C Sweet; D A Heiney; F L Grover Journal: Am J Transplant Date: 2006 Impact factor: 8.086
Authors: Andrew Jackson; Jonathan Cropper; Roger Pye; Frank Junius; Monique Malouf; Allan Glanville Journal: J Heart Lung Transplant Date: 2008-03 Impact factor: 10.247
Authors: Christian A Merlo; Eric S Weiss; Jonathan B Orens; Marvin C Borja; Marie Diener-West; John V Conte; Ashish S Shah Journal: J Heart Lung Transplant Date: 2009-08 Impact factor: 10.247
Authors: Martin Kosztowski; Sheng Zhou; Errol Bush; Robert S Higgins; Dorry L Segev; Sommer E Gentry Journal: Am J Transplant Date: 2018-12-15 Impact factor: 8.086
Authors: Don Hayes; Robert S Higgins; Ahmet Kilic; Stephen Kirkby; Amy L Pope-Harman; Thomas J Preston; Bryan A Whitson Journal: Lung Date: 2014-05-10 Impact factor: 2.584
Authors: J P Singer; P P Katz; A Soong; P Shrestha; D Huang; J Ho; M Mindo; J R Greenland; S R Hays; J Golden; J Kukreja; M E Kleinhenz; R J Shah; P D Blanc Journal: Am J Transplant Date: 2017-01-03 Impact factor: 8.086
Authors: Jens Gottlieb; Jacqueline Smits; Rene Schramm; Frank Langer; Roland Buhl; Christian Witt; Martin Strueber; Hermann Reichenspurner Journal: Dtsch Arztebl Int Date: 2017-03-17 Impact factor: 5.594
Authors: A W Castleberry; J T Martin; A A Osho; M G Hartwig; Z A Hashmi; G Zanotti; L K Shaw; J B Williams; S S Lin; R D Davis Journal: Am J Transplant Date: 2013-09-18 Impact factor: 8.086